Yield of screening for new aneurysms after treatment for subarachnoid hemorrhage.
D000328:Adult; D017542:Aneurysm, Ruptured / Q000150:complications* / Q000601:surgery / Q000628:therapy; D001925:Brain Damage, Chronic / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D002423:Cause of Death; D002533:Cerebral Angiography / Q000009:adverse effects / Q000379:methods*; D015331:Cohort Studies; D003661:Decision Support Techniques; D004621:Embolization, Therapeutic / Q000295:instrumentation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D002532:Intracranial Aneurysm / Q000150:complications* / Q000000981:diagnostic imaging; D008017:Life Expectancy; D008297:Male; D008390:Markov Chains; D008875:Middle Aged; D009010:Monte Carlo Method; D009026:Mortality; D019057:Quality-Adjusted Life Years; D012422:Rupture, Spontaneous; D055502:Secondary Prevention; D012680:Sensitivity and Specificity; D013345:Subarachnoid Hemorrhage / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control* / Q000601:surgery / Q000628:therapy; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome